In heterogeneous catalysis, the catalyst is in a different phase from the reactants. COA of Formula: C9H9BrO2, However, they have proven to be challenging because of the mutual inactivation of both catalysts. 214894-89-0, name is 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine. In an article£¬Which mentioned a new discovery about 214894-89-0
Thiazole substituted benzenesulfonamides are beta 3 adrenergic receptor agonists with very little beta 1 and beta. sub. 2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to lower triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to decrease gut motility. In addition, the compounds can be used to reduced neurogenic inflammation or as antidepressant agents. The compounds are prepared by coupling an aminoalkylphenyl-sulfonamide with an appropriately substituted epoxide. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for decreasing gut motility are also disclosed.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 214894-89-0, help many people in the next few years.COA of Formula: C9H9BrO2
Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem